Annual report pursuant to Section 13 and 15(d)

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail)

v3.6.0.2
Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Schedule of Equity Method Investments [Line Items]      
Equity in earnings $ 31,962 $ 28,126 $ 22,743
Equity in other comprehensive income (loss) (89) 3,119 (676)
Other Comprehensive Income Loss      
Schedule of Equity Method Investments [Line Items]      
Ending Balance   2,735 (896)
Cash Received      
Schedule of Equity Method Investments [Line Items]      
Revenues earned under ESA [1] 11,048 11,330 9,249
Receipt of excess cash distributions 22,716 29,468 27,352
Receipt under tax receivable agreement 6,158 5,052 6,357
Ending Balance 39,922 45,850 42,958
Other Revenue      
Schedule of Equity Method Investments [Line Items]      
Ending Balance 20,365 19,836 16,675
Revenues earned under ESA [1] (11,048) (11,330) (9,249)
Equity in Earnings      
Schedule of Equity Method Investments [Line Items]      
Equity in earnings (9,347) (8,510) (6,142)
Distributions from NCM      
Schedule of Equity Method Investments [Line Items]      
Receipt of excess cash distributions 11,483 15,396 14,778
Receipt under tax receivable agreement 3,173 2,744 3,763
Ending Balance (14,656) (18,140) (18,541)
Investment In NCM      
Schedule of Equity Method Investments [Line Items]      
Beginning Balance 183,755 178,939 178,853
Receipt of common units due to annual common unit adjustment 11,111 15,421 8,216
Receipt of excess cash distributions (11,233) (14,072) (12,574)
Receipt under tax receivable agreement (2,985) (2,308) (2,594)
Equity in earnings (9,347) (8,510) (6,142)
Equity in other comprehensive income (loss)   (2,735) 896
Ending Balance 189,995 183,755 178,939
Deferred Revenue      
Schedule of Equity Method Investments [Line Items]      
Beginning Balance (342,134) (335,219) (334,429)
Receipt of common units due to annual common unit adjustment (11,111) (15,421) (8,216)
Ending Balance (343,928) (342,134) (335,219)
NCM      
Schedule of Equity Method Investments [Line Items]      
Beginning Balance 183,755    
Beginning Balance (342,134)    
Ending Balance (343,928) (342,134)  
Ending Balance 189,995 183,755  
NCM | Other Comprehensive Income Loss      
Schedule of Equity Method Investments [Line Items]      
Equity in other comprehensive income (loss)   2,735 (896)
NCM | Other Revenue      
Schedule of Equity Method Investments [Line Items]      
Amortization of deferred revenue (9,317) (8,506) (7,426)
NCM | Equity in Earnings      
Schedule of Equity Method Investments [Line Items]      
Equity in earnings (9,347) (8,510) (6,142)
NCM | Deferred Revenue      
Schedule of Equity Method Investments [Line Items]      
Amortization of deferred revenue $ 9,317 $ 8,506 $ 7,426
[1] Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company's beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company's beverage concessionaire were approximately $11,489, $9,819 and $10,523 for the years ended December 31, 2014, 2015 and 2016, respectively.